269 related articles for article (PubMed ID: 9130694)
1. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
[TBL] [Abstract][Full Text] [Related]
2. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.
Verdaguer N; Schoehn G; Ochoa WF; Fita I; Brookes S; King A; Domingo E; Mateu MG; Stuart D; Hewat EA
Virology; 1999 Mar; 255(2):260-8. PubMed ID: 10069951
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray diffraction studies of a monoclonal antibody Fab fragment against foot-and-mouth disease virus and of its complex with the main antigenic site peptide.
Verdaguer N; Mateu MG; Bravo J; Tormo J; Giralt E; Andreu D; Domingo E; Fita I
Proteins; 1994 Feb; 18(2):201-3. PubMed ID: 8159669
[TBL] [Abstract][Full Text] [Related]
4. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
[TBL] [Abstract][Full Text] [Related]
5. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
6. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2.
Hewat EA; Blaas D
EMBO J; 1996 Apr; 15(7):1515-23. PubMed ID: 8612574
[TBL] [Abstract][Full Text] [Related]
7. A multiply substituted G-H loop from foot-and-mouth disease virus in complex with a neutralizing antibody: a role for water molecules.
Ochoa WF; Kalko SG; Mateu MG; Gomes P; Andreu D; Domingo E; Fita I; Verdaguer N
J Gen Virol; 2000 Jun; 81(Pt 6):1495-505. PubMed ID: 10811933
[TBL] [Abstract][Full Text] [Related]
8. Docking of a human rhinovirus neutralizing antibody onto the viral capsid.
Tormo J; Centeno NB; Fontana E; Bubendorfer T; Fita I; Blaas D
Proteins; 1995 Dec; 23(4):491-501. PubMed ID: 8749845
[TBL] [Abstract][Full Text] [Related]
9. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
10. Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge.
Thouvenin E; Laurent S; Madelaine MF; Rasschaert D; Vautherot JF; Hewat EA
J Mol Biol; 1997 Jul; 270(2):238-46. PubMed ID: 9236125
[TBL] [Abstract][Full Text] [Related]
11. Structure and dynamics of the GH loop of the foot-and-mouth disease virus capsid.
Azuma H; Yoneda S
J Mol Graph Model; 2009 Oct; 28(3):278-86. PubMed ID: 19734079
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
[TBL] [Abstract][Full Text] [Related]
13. Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.
Liu H; Smith TJ; Lee WM; Mosser AG; Rueckert RR; Olson NH; Cheng RH; Baker TS
J Mol Biol; 1994 Jul; 240(2):127-37. PubMed ID: 8027997
[TBL] [Abstract][Full Text] [Related]
14. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
[TBL] [Abstract][Full Text] [Related]
15. Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy.
Prasad BV; Burns JW; Marietta E; Estes MK; Chiu W
Nature; 1990 Feb; 343(6257):476-9. PubMed ID: 2153941
[TBL] [Abstract][Full Text] [Related]
16. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
[TBL] [Abstract][Full Text] [Related]
17. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
Schulze-Gahmen U; Rini JM; Wilson IA
J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
[TBL] [Abstract][Full Text] [Related]
18. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.
Lok SM; Kostyuchenko V; Nybakken GE; Holdaway HA; Battisti AJ; Sukupolvi-Petty S; Sedlak D; Fremont DH; Chipman PR; Roehrig JT; Diamond MS; Kuhn RJ; Rossmann MG
Nat Struct Mol Biol; 2008 Mar; 15(3):312-7. PubMed ID: 18264114
[TBL] [Abstract][Full Text] [Related]
19. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
[TBL] [Abstract][Full Text] [Related]
20. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
